
Genentech Plans North Carolina Manufacturing Facility, Expanding Roche’s US Footprint
The biotechnology company Genentech, a member of the Roche Group, announced on May 12, 2025, that it will invest more than $700 million in a new, state-of-the-art drug manufacturing facility in Holly Springs, NC, Genentech’s first facility to be built on …